Humoral and cell mediated immune responses to a pertussis containing vaccine in pregnant and nonpregnant women

Vaccine

Volumn 33, Issue 33, 2015, Pages 4117-4123

  Huygen, Kris ^a   Caboré, Raïssa Nadège ^a   Maertens, Kirsten ^b   Van Damme, Pierre ^b   Leuridan, Elke ^b  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cell mediated immunity; Diphtheria; Pertussis; Pregnancy; Tetanus; Vaccination

Indexed keywords

ACELLULAR VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TOXIN; FILAMENTOUS HEMAGGLUTININ; GAMMA INTERFERON; HEMAGGLUTININ; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 13; PERTACTIN; PERTUSSIS TOXIN; POKEWEED MITOGEN; TETANUS TOXIN; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; PERTUSSIS; PREGNANT WOMAN; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; VACCINATION; ADOLESCENT; BLOOD; CELL PROLIFERATION; COMPARATIVE STUDY; IMMUNOLOGY; MONONUCLEAR CELL; PILOT STUDY; PREGNANCY; SECRETION (PROCESS); TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CELL PROLIFERATION; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; PILOT PROJECTS; PREGNANCY; TIME FACTORS; YOUNG ADULT;

EID: 84949656002     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.108     Document Type: Article

References (39)

1. Cherry J.D. Pertussis: challenges today and for the future. PLoS Pathog 2013, 9(7):e1003418.
2. Huygen K., Rodeghiero C., Govaerts D., et al. Bordetella pertussis seroprevalence in Belgian adults aged 20-39 years. Epidemiol Infect 2014, 724-728.
3. Swamy G.K., Wheeler S.M. Neonatal pertussis, cocooning and maternal immunization. Expert Rev Vaccines 2014, 1-8.
4. Zepp F., Heininger U., Mertsola J., et al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis 2011, 11:557-570.
5. Healy C.M., Rench M.A., Wootton S.H., Castagnini L.A. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J 2015.
6. Leuridan E., Hens N., Peeters N., de Witte L., Van der Meeren O., Van Damme P. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011, 30(7):608-610.
7. Updated Recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. Morb Mortal Wkly Rep 2013, 62:131-135.
8. UK Department of Health Pertussis (whooping cough) vaccination programme for pregnant women introduced on 1 October 2012. 2013, http://immunisation dh gov uk/pertussis-pregnant. Accessed 26.03.13.
9. Ireland's Health Service Executive National Immunisation Programme. Whooping cough (pertussis) 2013, http://www immunisation ie/en/AdultImmunisation/WhoopingCoughPertussis/ - what_Vacc_preg_need.
10. Superior Health Council Belgium Pertussis Vaccination. Update 2013 2013, Superior Health Council.
11. Gall S.A., Myers J., Pichichero M. Maternal immunization with tetanus-diphteria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011, 204(334):e1-e5.
12. Hardy-Fairbanks A.J., Pan S.J., Decker M.D., et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013, 32(11):1257-1260.
13. Donegan K., King B., Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014, 349:g4219.
14. Munoz F.M., Bond N.H., Maccato M., et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014, 311(17):1760-1769.
15. Amirthalingam G., Andrews N., Campbell H., et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014.
16. Mills K.H.G., Ross P.J., Allen A.C., Wilk M.M. Do we need a new vaccine to control the re-mergence of pertussis?. Trends Microbiol 2014, 22(2):49-52.
17. Vermeulen F., Dirix V., Verscheure V., et al. Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose. Vaccine 2013, 31(15):1981-1986.
18. Rieber N., Graf A., Hartl D., Urschel S., Belohradsky B.H., Liese J. Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune responses. PLoS ONE 2011, 6(3):e17271.
19. Jahnmatz M., Ljungman M., Netterlid E., Jenmalm M.C., Nilsson L., Thorstensson R. Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine. Clin Vaccine Immunol 2014, 1301-1308.
20. Rieber N., Graf A., Belohradsky B.H., et al. Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination. Vaccine 2008, 26(52):6929-6935.
21. Guiso N., Njamkepo E., Vie le S.F., et al. Long-term humoral and cell-mediated immunity after acellular pertussis vaccination compares favourably with whole-cell vaccines 6 years after booster vaccination in the second year of life. Vaccine 2007, 25(February (8)):1390-1397.
22. Meyer C.U., Zepp F., Decker M., et al. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration. Clin Vaccine Immunol 2007, 14(3):288-292.
23. Esposito S., Bosis S., Morlacchi L., Baggi E., Sabatini C., Principi N. Can infants be protected by means of maternal vaccination. Clin Microbiol Infect 2012, 18(Suppl 5):85-92.
24. Yamaguchi K., Hisano M., Isojima S., et al. Relationship of Th1/Th2 cell balance with the immune response to influenza vaccine during pregnancy. J Med Virol 2009, 81(11):1923-1928.
25. Kay A.W., Fukuyama J., Aziz N., et al. Enhanced natural killer-cell and T-cell responses to influenza A virus during pregnancy. Proc Natl Acad Sci U S A 2014, 111(40):14506-14511.
26. Leuridan E., Hoang T.T., Dang D.A., Van D.P. Pertussis vaccination and pregnancy. Clin Infect Dis 2013 Aug, 57(3):471-472.
27. Launois P., Drowart A., Bourreau E., et al. T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections. Clin Dev Immunol 2011, Article ID 6 40309.
28. Vincent M., Rodeghiero C., Eylenbosch R., et al. Pertussis serodiagnosis in Belgium from 1990 to 2009. Clin Vaccine Immunol 2011, 18(4):588-594.
29. Hallander H.O., Ljungman M., Storsaeter J., Gustafsson L. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS 2009, 117:797-807.
30. Ross P.J., Sutton C.E., Higgins S., et al. Relative Contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine. PLoS Pathog 2013, 9(4):e1003264.
31. Lin H., Mossmann T.R., Guilbert L., Tuntipopipat S., Wegmann T.G. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993, 151:4562-4573.
32. Wilczynski J.R. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 2005, 122:136-143.
33. Reinhard G., Noll A., Schlebusch H., Mallmann P., Ruecker A.V. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998, 245:933-938.
34. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000, 47(2):87-103.
35. Aris A., Lambert F., Bessette P., Moutquin J.M. Maternal circulating interferon-gamma and interleukin-6 as biomarkers of Th1/Th2 immune status throughout pregnancy. J Obstet Gynaecol Res 2008, 34(1):7-11.
36. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010, 63(6):425-433.
37. Munoz-Suano A., Hamilton A.B., Betz A.G. Gimme shelter: the immune system during pregnancy. Immunol Rev 2011, 241(1):20-38.
38. Somerset D.A., Zheng Y., Kilby M.D., Sansom D.M., Drayson M.T. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004, 112(1):38-43.
39. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol 1989, 19(12):2237-2242.